ATNAHS PHARMA UK C.O. WAYMADE PLC

Company Type: Trader / Specialty Pharmaceutical Company

Company Introduction:

Atnahs Pharma UK Limited is a specialty pharmaceutical company based in the United Kingdom. Its primary business model involves acquiring, developing, and commercializing established pharmaceutical brands and products across a diverse range of therapeutic areas. Atnahs Pharma focuses on managing the full lifecycle of these products, encompassing regulatory affairs, supply chain management, and commercialization strategies. The company does not typically own or operate its own manufacturing facilities; instead, it collaborates with third-party contract manufacturing organizations (CMOs) for the production of its pharmaceutical products. Therefore, its operations are centered on portfolio management, brand acquisition, and distribution, positioning it primarily as a trading and marketing entity within the pharmaceutical sector rather than a direct manufacturer.

Waymade PLC is a well-established independent pharmaceutical wholesaler and distributor, also headquartered in the United Kingdom. It specializes in the distribution of prescription medicines, over-the-counter products, and various other healthcare items to pharmacies, hospitals, and other healthcare providers. Waymade PLC's core business is quintessential pharmaceutical trading, concentrating on logistics, distribution, and efficient supply chain management.

The notation "C.O." (care of) often indicates a business relationship, such as Waymade PLC providing distribution services or acting as a logistics partner for Atnahs Pharma UK, or it could refer to a shared administrative arrangement. It does not imply that they are a single, combined entity. Both Atnahs Pharma UK and Waymade PLC are primarily based in the United Kingdom. While their products and services may have an international reach, they are not inherently Indian companies; their main operations and headquarters are located in the UK.

Atnahs Pharma UK is a specialty pharmaceutical company focused on acquiring, developing, and marketing mature branded medicines across various therapeutic areas. Waymade PLC is a pharmaceutical distributor, often involved in the supply chain for such products.

The product portfolio of Atnahs Pharma UK globally includes a range of established brands. These generally fall within therapeutic areas such as cardiovascular and metabolic diseases, neurology and pain, women's health, respiratory, dermatology, oncology, and anti-infectives.

Examples of brands owned by Atnahs Pharma UK include Tildiem (Diltiazem), Fucidin (Fusidic acid), Fucicort (Fusidic acid/Betamethasone), Serevent (Salmeterol), Zestril (Lisinopril), Zestoretic (Lisinopril/Hydrochlorothiazide), Inderal (Propranolol), Tenormin (Atenolol), Tenoretic (Atenolol/Chlorthalidone), Imdur (Isosorbide Mononitrate), Atacand (Candesartan), Atacand Plus (Candesartan/Hydrochlorothiazide), Plenadren (Hydrocortisone modified-release), Kadian (Morphine Sulfate extended-release), Lioresal (Baclofen), and Synarel (Nafarelin).

The availability and specific marketing or distribution of these products in India by Atnahs Pharma UK or Waymade PLC would depend on local regulatory approvals, licensing agreements with Indian pharmaceutical companies, and specific distribution channels established within the Indian market. It is common for such international companies to partner with local entities for product manufacturing, marketing, and sales in India.